methods among the patients, and this variation of arterial blood pressure determination may have contributed to the results. Compounding this method-related variability is the fact that atrial fibrillation patients show relatively large short-term blood pressure fluctuations because of variability in left ventricular stroke volume.
Four patients in the study were treated with norepinephrine, yet the dose was not reported. Norepinephrine affects StO 2 [3] , so dose information is needed in order to assess the risk that this treatment may have affected the results. Similarly, the study does not report whether patients received interventions against causes of elevated heart rate, such as infection, endocrine imbalance, anemia, or pulmonary embolism [4] . These interventions can interfere with the effects of esmolol, so information on their use should be included.
Studies like those of Fornier and colleagues [1] should attend to these points in order to provide the most reliable insights into improving care for patients experiencing postoperative atrial fibrillation.
